DRKS00000001已完成不适用
EWOG - MDS 98 Myelodysplastic Syndromes in ChildhoodProspective Study of the Diagnosis and Treatmentof Myelodysplastic Syndromes (MDS) in Childhood - EWOG-MDS 98 - EWOG-MDS 98
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 714
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- one 至 18 Years（—）
- 性别
- All
入选标准
- •All children and adolescents with MDS under the age of 19 diagnosed between July 1998 and June 2002 are registered as study patients.
排除标准
- •- Children with Down syndrome
- •- Children with the following cytogenetic or molecular abnormalities:
- •t(8;21)(q22;q22) [AML1/ETO fusion gene]
- •t(15;17)(q22;q12) [PML/RAR´´ rearrangement]
- •inv(16)(p13q22) [CBF$/MYH11rearrangement]
- •- Children with the typical clinical and cytogenetic features of AML FAB M7 who present with < 30% blasts in the BM and PB
- •- Concomitant illness precluding therapy according to protocol
- •- No informed consent by the patient or legal guardian
- •- Morphological diagnosis could not be confirmed
研究者
相似试验
招募中
不适用
Australian Myelodysplastic Syndromes (MDS) Patient RegistryMyelodysplastic SyndromesCancer - Other cancer typesBlood - Haematological diseasesACTRN12620001012965Monash University300
未知
不适用
Registration Program for Myelodysplastic Syndromes and Aplastic AnemiaJPRN-UMIN000000694Keio University School of Medicine50
招募中
不适用
Clinical and Genomic Registry of MDS in AsiaMyelodysplastic SyndromesNCT03169296The University of Hong Kong2,600
进行中（未招募）
1 期
Darbepoetin alfa in Anaemic Subjects With Low Risk Myelodysplastic Syndromes - Companion Studyow or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)MedDRA version: 16.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2013-000727-13-BEAmgen Inc
已完成
不适用
Transient myeloproliferative disease in children with Down syndrome Part A: Screening newborns with Down syndrome for TMD Part B: Treatment and follow-up of children with Down syndrome and TMDDown syndrome acute myeloid leukemiatransient myeloproliferative syndrome100243241008362410028920NL-OMON31343Erasmus MC, Universitair Medisch Centrum Rotterdam811